Cellular reaction in trophoblastic tumours.

Area of Science:

• Gynecologic Oncology
• Immunology
• Pathology

Background:

• Gestational trophoblastic diseases (GTD) encompass a spectrum of placental-derived tumors.
• The host immune response to tumors is a critical factor in disease progression and treatment efficacy.
• Understanding the cellular infiltrate in GTD may reveal prognostic markers and therapeutic targets.

Purpose of the Study:

• To investigate the presence and intensity of mononuclear cell infiltration in gestational choriocarcinoma, invasive moles, and malignant trophoblastic teratomas.
• To correlate the degree of cellular reaction with clinical and pathological features, including response to therapy and survival rates.
• To explore the potential immunological significance of mononuclear cell infiltrates in GTD.

Main Methods:

• Histopathological examination of 41 gestational choriocarcinomas, 10 invasive moles, and 13 malignant trophoblastic teratomas.
• Grading the intensity of the mononuclear cell reaction within the tumors.
• Correlation analysis between cellular reaction grade and clinical outcomes (therapy response, survival) and other histological features (e.g., vascular invasion).

Main Results:

• A significantly better response to therapy and survival rate was observed in gestational choriocarcinoma patients with a 'severe' mononuclear cell reaction compared to those with a 'mild' reaction.
• No significant relationship was found between cellular reaction and pathological/clinical features in invasive moles.
• While generally poor, a marked cellular reaction was noted in one case of trophoblastic teratoma with sustained remission; vascular invasion positively correlated with treatment response.

Conclusions:

• Mononuclear cell infiltrates in gestational choriocarcinoma likely represent an immune response to tumor antigens.
• A strong cellular reaction appears to favorably influence the response to chemotherapy, suggesting a role in tumor cell death and rejection.
• The findings suggest that the host immune response is a significant factor in the prognosis and treatment of gestational choriocarcinoma.